Conclusion
The results of this study reflect the influence of demographic, clinical
characteristics and technology of the children receiving NIV on
long-term therapy outcomes particularly age, diagnostic category and
specific underlying conditions, added comorbidities and technologies in
use and technology type. These results are important for clinicians, as
they can use available information to discuss goals and expectations of
NIV with children and families even prior to NIV initiation and optimize
resources to ensure adequate follow up management and improve the
success children may achieve using NIV therapy.